Full Text
PAR11 WITHDRAWAL OF COX-2 INHIBITOR ROFECOXIBAND VALDECOXIB- IMPACT ON NSAIDAND PPI PRESCRIPTIONS AND EXPENDITURES

Abstract

Authors

SX Sun KY Lee CT Bertram

Back to Volume 9, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×